Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Meyer

Showing results (421-430 of 476) with videos related to

Pageof 48
Sort By:
Human Molecular Genetics|March 2, 2012
NIPA1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosisHylke M Blauw, Wouter van Rheenen, Max Koppers, et al.
Brain : a Journal of Neurology|March 18, 2016
Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosisPauline Vercruysse, Jérôme Sinniger, Hajer El Oussini, et al.
Annals of Neurology|December 19, 2019
Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral SclerosisAlbert C Ludolph, Johannes Dorst, Jens Dreyhaupt, et al.
Bone Marrow Transplantation|April 3, 2026
Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantationKristina Maas-Bauer, Thomas Meyer, Mehtap Yücel, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 17, 2026
ALS motor phenotypes: a revised 'OPM' classificationThomas Meyer, Nicola Ticozzi, Markus Weber, et al.
Annals of Clinical and Translational Neurology|April 1, 2021
Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatmentMaren Freigang, Claudia D Wurster, Tim Hagenacker, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 30, 2021
Caregivers' divergent perspectives on patients' well-being and attitudes towards hastened death in Germany, Poland and SwedenPeter M Andersen, Magdalena Kuźma-Kozakiewicz, Jürgen Keller, et al.
Annals of Clinical and Translational Neurology|February 22, 2022
Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophyCamilla Binz, Alma Osmanovic, Nele H Thomas, et al.
The Lancet. Neurology|June 24, 2018
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialAlbert C Ludolph, Joachim Schuster, Johannes Dorst, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 20, 2026
Minimum important slowing of disease progression as determined by the ALS functional rating scale - a survey of patient expectations toward disease-modifying drugs in ALSThomas Meyer, André Maier, Torsten Grehl, et al.
Pageof 48

Showing results (421-430 of 476) with videos related to

Sort By:
Pageof 48
Human Molecular Genetics|March 2, 2012
NIPA1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosisHylke M Blauw, Wouter van Rheenen, Max Koppers, et al.
Brain : a Journal of Neurology|March 18, 2016
Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosisPauline Vercruysse, Jérôme Sinniger, Hajer El Oussini, et al.
Annals of Neurology|December 19, 2019
Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral SclerosisAlbert C Ludolph, Johannes Dorst, Jens Dreyhaupt, et al.
Bone Marrow Transplantation|April 3, 2026
Mutational landscape changes of AML in patients relapsing after allogeneic hematopoietic cell transplantationKristina Maas-Bauer, Thomas Meyer, Mehtap Yücel, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 17, 2026
ALS motor phenotypes: a revised 'OPM' classificationThomas Meyer, Nicola Ticozzi, Markus Weber, et al.
Annals of Clinical and Translational Neurology|April 1, 2021
Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatmentMaren Freigang, Claudia D Wurster, Tim Hagenacker, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 30, 2021
Caregivers' divergent perspectives on patients' well-being and attitudes towards hastened death in Germany, Poland and SwedenPeter M Andersen, Magdalena Kuźma-Kozakiewicz, Jürgen Keller, et al.
Annals of Clinical and Translational Neurology|February 22, 2022
Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophyCamilla Binz, Alma Osmanovic, Nele H Thomas, et al.
The Lancet. Neurology|June 24, 2018
Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialAlbert C Ludolph, Joachim Schuster, Johannes Dorst, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 20, 2026
Minimum important slowing of disease progression as determined by the ALS functional rating scale - a survey of patient expectations toward disease-modifying drugs in ALSThomas Meyer, André Maier, Torsten Grehl, et al.
Pageof 48